5E Advanced Materials, Inc. — Form 10-K Summary
Period clarification: The supplied filing is the annual report for the fiscal year ended June 30, 2022, with fiscal 2021 comparisons; it is not a 2020 Q4 filing. The 10-K was signed September 28, 2022.
Business context
5E is an exploration-stage company developing the Fort Cady boron and lithium project in California. It had not generated revenue from mineral production and reported no known Proven or Probable Mineral Reserves. Its strategy is to develop boric acid and lithium carbonate production, with potential downstream boron advanced materials. The company completed its reorganization and began trading on Nasdaq as FEAM in March 2022.
Financial performance and liquidity
| Metric | FY2022 | FY2021 |
|---|---|---|
| Revenue | $0; no mineral-product revenue | $0; no mineral-product revenue |
| Operating expenses | $67.8 million | $17.6 million |
| Net loss | $66.7 million | $19.3 million |
| Loss per share | $1.63 | $0.56 |
| Cash from operating activities | $(28.6) million* | $(10.9) million |
| Cash from investing activities | $(11.4) million | $(13.0) million |
| Cash from financing activities | $30.6 million | $37.8 million |
| Cash and cash equivalents at year-end | $31.1 million | $40.8 million |
| Working capital at year-end | $25.2 million | $39.3 million |
Other key figures: Total assets were $70.9 million and total liabilities were $8.2 million at June 30, 2022. Year-end debt was $186,000, primarily vehicle notes; the company also reported $28.6 million in purchase-order commitments. No operating margin is meaningful because the company had no product revenue.
General and administrative expense rose to $54.7 million from $11.6 million. The increase included $37.7 million of share-based compensation, including $31.0 million related to Blue Horizon Advisors, and $4.3 million of reorganization and Nasdaq-listing costs. Project expenses increased to $12.9 million from $6.0 million, mainly with SSBF preparation and engineering activity.
*The detailed consolidated cash-flow statement reports operating cash use of $28.615 million and a cash decrease of $9.393 million. The MD&A summary instead reports $28.976 million of operating cash use and a $9.754 million decrease; the filing text does not explain the discrepancy.
Material changes and project progress
- The company shifted its planned large-scale project focus from boron and sulphate of potash (SOP) to boron and lithium, and added a small-scale boron facility (SSBF) ahead of the proposed large-scale complex.
- Management targeted SSBF construction completion around calendar year-end 2022, with an engineered capacity of approximately 2,000 tons of boric acid per year. Estimated total cost was $45–$55 million, including $3.4 million for injection-recovery wells; $25.6 million had been spent by June 30, 2022.
- Management targeted initial commercial production in 2025, contingent on successful SSBF construction and operation, funding, and development of the large-scale complex. Initial large-scale boric acid capacity was targeted at approximately 250,000 tons per year, with potential capacity up to 500,000 tons per year. Early lithium carbonate capacity estimates were “up to several thousand tons per year”; no clear specific target was provided.
- Project-scope changes and inflation materially increased the expected large-scale capital budget versus prior estimates. The filing provides no updated quantified total for that budget and says estimates remain subject to change.
- The February 2022 Initial Assessment Report estimated 97.55 million tons of Measured plus Indicated Mineral Resources and 11.43 million tons of Inferred Mineral Resources. These are resources, not reserves, and do not establish economic viability.
Outlook, risks and unusual items
- In August 2022, after year-end, the company issued $60 million of senior secured convertible notes, maturing August 2027, with a 4.50% cash-pay or 6.00% note-pay interest rate and a $17.60 conversion price. The notes are secured by substantially all company assets and include debt and lien restrictions. Management said cash on hand plus note proceeds were expected to fund the next 12 months; further development of the large-scale project will require substantial additional financing.
- Customer discussions and letters of intent with Compass Minerals, Borman Specialty Materials, Rose Mill and Corning were non-binding; the company had no binding product supply agreements.
- Key risks include ongoing losses and cash burn, dependence on Fort Cady, substantial funding needs, cost escalation and supply-chain delays, permitting and infrastructure needs (including water, power and natural gas), commodity-price volatility, and uncertainty about extraction, recoveries and commercial viability.
- The company reported a material weakness in internal control over financial reporting related to insufficient segregation of accounting-system administrative duties. It said remediation had begun through additional accounting hires and implementation of a more robust system. Management concluded disclosure controls were effective; the auditor did not express an opinion on internal-control effectiveness.
- The filing reported no material pending legal proceedings. No income tax benefit was recorded, as deferred tax assets were subject to a full valuation allowance.
Important facts for investors to verify
- Whether SSBF construction, commissioning, operating performance and cost stayed on schedule, and whether its results support the large-scale design and economics.
- The updated large-scale capital requirement, remaining funding needs, cash runway, and the convertible notes’ covenants, collateral, interest and potential dilution.
- Progress toward a technical and economic study, any conversion of resources into reserves, and demonstrated boron and lithium recovery rates and product quality.
- Whether non-binding customer discussions convert into binding offtake agreements and whether target production capacities and the 2025 commercial-production objective remain achievable.
- The operating-cash-flow discrepancy between the MD&A summary and the detailed cash-flow statement, and remediation of the disclosed internal-control material weakness.